VULCAN (AFP) – An Austrian company hopes to revive the world’s oldest medical treatment for brain disorders.
Inova Neurology says its technology could help treat people who have suffered from the most common degenerative neurological diseases such as Alzheimer’s and Parkinson’s.
Its founder, Bernhard Mäkel, told AFP on Monday the new product could cure conditions such as Parkinson’s disease, Alzheimer’s disease and Tourette’s syndrome.
“For me, it’s an extraordinary opportunity to do something which has never been done before,” he said.
“It will not only save lives, but also change the way we think about diseases.”
The company has already tested the product in trials in the US, Europe and Asia.
Mäkel said his company was currently recruiting patients in a dozen countries, including the United States, Britain, Australia, New Zealand and Canada.
The treatment will cost about US$300 per patient.
Inova expects the drug to reach a market of between 300,000 and 1 million people in the next two years.
“This is the most important part of our strategy,” Mäkels said.
The company, which will announce its first clinical trials in 2018, has already started working with its first patient.
“The results are amazing, we are so thrilled,” Manker told AFP.
The inventor said the technology was “quite a bit” more than a “brain pill”.
“The patient doesn’t have to be a neurologist, but the treatment will be the same for everyone,” he added.
“We have to look at the patient’s whole picture and think about their life.”
The treatment has not yet been tested on humans.